CHA sent a comment letter to the FDA on draft guidance that recommends how and when manufacturers provide additional information in drug shortage notifications to the agency. Our letter urges the FDA to address the specific challenges facing the pediatric drug supply chain through transparency requirements, developing proactive shortage mitigation plans, and ensuring an accounting of pediatric drugs on the FDA drug shortages list.
CHA Submits Comments on FDA Drug Shortage Guidance
CHA Releases New Report on the Impact of America’s Children’s Hospitals
Data highlights overwhelming preference and support for ensuring access to specialized care at children's hospitals.
How Children's Hospitals Are Improving Behavioral and Mental Health Care
Explore how Children’s Hospital Association and our members are improving mental and behavioral health care amid a crisis.